Immunocore (NASDAQ:IMCR) Research Coverage Started at Robert W. Baird
Robert W. Baird began coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $84.00 price target on the stock. A number of other research firms have also commented on IMCR. Canaccord Genuity Group began coverage on Immunocore […]
More Stories
ICU Medical (NASDAQ:ICUI) PT Raised to $198.00
ICU Medical (NASDAQ:ICUI – Free Report) had its price target upped by KeyCorp from $147.00 to $198.00 in a report...
Jasper Therapeutics (NASDAQ:JSPR) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report released...
Monster Beverage (NASDAQ:MNST) Price Target Raised to $57.00 at Bank of America
Monster Beverage (NASDAQ:MNST – Free Report) had its price target increased by Bank of America from $56.00 to $57.00 in...
BNP Paribas Upgrades Stora Enso Oyj (OTCMKTS:SEOAY) to “Hold”
BNP Paribas upgraded shares of Stora Enso Oyj (OTCMKTS:SEOAY – Free Report) to a hold rating in a research report...
Hut 8 Corp. (NASDAQ:HUT) Receives $16.50 Consensus Target Price from Analysts
Hut 8 Corp. (NASDAQ:HUT – Get Free Report) has been given an average rating of “Buy” by the six brokerages...
Bank of America Increases Vertiv (NYSE:VRT) Price Target to $130.00
Vertiv (NYSE:VRT – Free Report) had its price target hoisted by Bank of America from $115.00 to $130.00 in a...